RenovoRx RNXT
NASDAQ RNXT
$1.56 -0.01 (-0.64%)
At close: Sep 30, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Convertible Debt (2021)

Updated

RenovoRx's Convertible Debt came in at $5.3 million for Q4 2021, unchanged from the prior quarter.

Analysis

RenovoRx (RNXT) Convertible Debt (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn
10 RenovoRx 70.84 Mn 70.84 Mn 766,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 5.30 Mn
Sep 30, 2021 5.30 Mn
API Access

RenovoRx Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=RNXT&period=max&api_key=YOUR_API_KEY